US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.6100
  • -0.0240-3.79%
Trading Nov 27 10:05 ET
3.10MMarket Cap-128P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Matinas BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Matinas BioPharma Earnings Reports

  • Matinas BioPharma | 10-Q: Q3 2024 Earnings Report

    Nov 13 17:23 ET

  • Matinas BioPharma | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:53 ET

  • Matinas BioPharma | 8-K: Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

    Aug 14 16:53 ET

  • Matinas BioPharma | 8-K: Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

    May 9 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data